Ibrance

Indicated For

HR+, HER2- metastatic breast cancer

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get Ibrance (palbociclib) at Low or No Cost Ibrance (palbociclib) is a prescription medication used to treat certain types of advanced or metastatic breast cancer in adults. It works by blocking proteins that help cancer cells grow and divide, slowing the progression of hormone receptor-positive, HER2-negative breast cancer when combined with other therapies like hormone treatments. This guide explains how the **Pfizer Patient Assistance Program (PAP)** can provide Ibrance for free to eligible patients facing financial hardship. ## Who Qualifies for the Program? The Pfizer PAP is designed as a safety-net program for patients who cannot afford their medications due to limited income and lack of insurance coverage. Key eligibility criteria include: - **Residency**: You must live in the U.S. or a U.S. territory. - **Age**: Be 18 years or older. - **Prescription**: Have a valid prescription for Ibrance from a U.S.-licensed healthcare provider for an FDA-approved use, typically in an outpatient setting. - **Income Limits**: Household income generally must be at or below **400% of the Federal Poverty Level (FPL)**. Specific thresholds vary by household size—for example, around $50,000 for an individual or $70,000 for a couple, up to approximately $200,000 for larger families. - **Insurance Status**: Primarily for uninsured patients, those with Medicare (including Part D) who are not eligible for Extra Help or Low-Income Subsidy (LIS), Medicaid patients under certain conditions, or underinsured individuals without other funding options. **Commercially insured patients are not eligible**, even if out-of-pocket costs are high. Before applying to Pfizer PAP, you may need to explore other resources, such as Medicaid eligibility, diagnosis-specific Independent Charitable Patient Assistance Programs (ICPAPs), or Medicare Prescription Payment Plan enrollment (required for Medicare Part D patients starting 2025). ## About Ibrance (palbociclib) Ibrance is a targeted therapy capsule taken orally, usually once daily for 21 days followed by 7 days off, in combination with an aromatase inhibitor or fulvestrant. It's not a cure but helps extend progression-free survival in HR+/HER2- metastatic breast cancer. Common side effects include low white blood cell counts (neutropenia), fatigue, nausea, and infections—discuss risks with your doctor. Always take as prescribed and report side effects promptly. ## Income Eligibility Breakdown Income limits are based on **400% of the FPL** and adjust annually for household size. Here's a simplified table based on program guidelines (exact figures may vary; check current FPL at application): | Household Size | Approximate Annual Income Limit | |----------------|---------------------------------| | 1 (Individual) | $50,000 | | 2 (Couple) | $70,000 | | 3 | $85,000–$90,000 | | 4 | $100,000–$110,000 | | 5+ | Up to ~$200,000 for larger families | **Notes**: Provide proof like W-2, tax returns, or pay stubs. No income requires a physician letter or notarized family statement. Medical expenses may factor in some cases. ## Insurance Requirements - **Uninsured**: Fully eligible if other criteria met. - **Medicare/Medicaid**: Must confirm ineligibility for Extra Help/LIS or other aid; provide Medicare ID, plan details, and proof of denials. Medicare Part D patients need to enroll in the Prescription Payment Plan and apply to ICPAPs first (effective 2025). - **Underinsured**: Only if no alternate funding available; commercial insurance disqualifies you. - **Exclusions**: Commercial plans, certain government programs without prior denials. Pfizer may help check Medicaid eligibility or prior authorizations, but PAP is a last resort. ## Step-by-Step Application Process 1. **Visit Pfizer RxPathways**: Go to www.PfizerRxPathways.com and use the Program Finder. Enter "Ibrance" (palbociclib) and follow prompts.[1][2] 2. **Choose Application Method**: Online via Pfizer PAP Connect (for select meds), downloadable forms, phone at **(800) 505-4426**, or fax. Your doctor must participate.[1][9] 3. **Gather Documents**: - Proof of income (W-2, tax return, pay stubs). - Proof of residency (utility bill, etc.). - Valid Ibrance prescription. - Physician enrollment form (includes DEA/State license).[2][6][9] - Insurance cards (front/back) if applicable, plus denial proofs. 4. **Submit**: Doctor completes their section; patient handles income/residency. Fax or mail as instructed.[9] 5. **Wait for Notification**: Approval/denial in **2-4 weeks**; both you and your provider get letters.[1][9] ## Timeline and Delivery - **Processing**: 2-3 weeks typically, up to 4 weeks.[1][9] - **Supply**: 90-day quantities shipped free to your doctor's office or home.[9] - **Reauthorization**: Required annually or every 12 months with new financials; refills vary but need doctor coordination.[9] ## Alternatives if Denied - **Pfizer Oncology Together**: Co-pay help for commercial insurance, free trial vouchers, prior auth/appeal support.[4][5] - **ICPAPs**: Patient access networks for breast cancer (apply first, provide denials).[7] - **Medicaid/Extra Help**: Pfizer can assist applications.[3] - **Other PAPs**: Check RxAssist.org or NeedyMeds for biosimilars (none currently for Ibrance). - **Manufacturer Hotline**: Call (800) 505-4426 for guidance. ## Disclaimer This guide is for informational purposes only and based on available program details as of latest updates. Eligibility rules change; always verify at PfizerRxPathways.com or by phone. Not medical advice—consult your healthcare provider. Pfizer PAP is a joint program of Pfizer Inc. and Pfizer Patient Assistance Foundation; free meds via the Foundation. Reapply as required; undue hardship claims reviewed case-by-case.

Program information last verified: March 29, 2026